Carregant...
When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
BACKGROUND: We examined sponsorship of published cost-effectiveness analyses of statin use for cardiovascular (CV) prevention, and determined whether the funding source is associated with study conclusions. METHODS AND FINDINGS: We searched PubMed/MEDLINE (up to June 2011) to identify cost-effective...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3704635/ https://ncbi.nlm.nih.gov/pubmed/23861972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0069462 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|